17-78993858-G-A

Variant names:

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong

The NM_001159773.2(CANT1):c.898C>T(p.Arg300Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 1,597,814 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R300H) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)

Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

CANT1
NM_001159773.2 missense

Scores

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:3

Conservation

PhyloP100: 7.57

Publications

7 publications found

Variant links:

Genes affected

CANT1 (HGNC:19721): (calcium activated nucleotidase 1) This protein encoded by this gene belongs to the apyrase family. It functions as a calcium-dependent nucleotidase with a preference for UDP. Mutations in this gene are associated with Desbuquois dysplasia with hand anomalies. Alternatively spliced transcript variants have been noted for this gene.[provided by RefSeq, Mar 2010]

CANT1 Gene-Disease associations (from GenCC):

Desbuquois dysplasia 1
Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
Desbuquois dysplasia
Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

CANT1 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PM2

Very rare variant in population databases, with high coverage;

PM5

Other missense variant is known to change same aminoacid residue: Variant chr17-78993857-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 280.Status of the report is criteria_provided_single_submitter, 1 stars.

PP3

MetaRNN computational evidence supports a deleterious effect, 0.994

PP5

Variant 17-78993858-G-A is Pathogenic according to our data. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78993858-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
CANT1	NM_001159773.2 link	c.898C>T	p.Arg300Cys	missense_variant	Exon 5 of 5	ENST00000392446.10	NP_001153245.1	Q8WVQ1-1A0A024R8U8
CANT1	NM_001159772.2 link	c.898C>T	p.Arg300Cys	missense_variant	Exon 6 of 6		NP_001153244.1	Q8WVQ1-1A0A024R8U8
CANT1	NM_138793.4 link	c.898C>T	p.Arg300Cys	missense_variant	Exon 4 of 4		NP_620148.1	Q8WVQ1-1A0A024R8U8

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
CANT1	ENST00000392446.10 link	c.898C>T	p.Arg300Cys	missense_variant	Exon 5 of 5	1	NM_001159773.2	ENSP00000376241.4		Q8WVQ1-1

Frequencies

GnomAD3 genomes

AF:

0.00000657

AC:

AN:

152224

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.0000241

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.00

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.0000175

AC:

AN:

229118

AF XY:

0.0000318

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.00

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.0000570

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.0000192

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

0.0000138

AC:

AN:

1445590

Hom.:

Cov.:

AF XY:

0.0000209

AC XY:

AN XY:

718438

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

33328

American (AMR)

AF:

0.00

AC:

AN:

44130

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

25902

East Asian (EAS)

AF:

0.0000254

AC:

AN:

39402

South Asian (SAS)

AF:

0.0000584

AC:

AN:

85636

European-Finnish (FIN)

AF:

0.00

AC:

AN:

44202

Middle Eastern (MID)

AF:

0.000174

AC:

AN:

5744

European-Non Finnish (NFE)

AF:

0.0000117

AC:

AN:

1107318

Other (OTH)

AF:

0.00

AC:

AN:

59928

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.505

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.00000657

AC:

AN:

152224

Hom.:

Cov.:

AF XY:

0.00

AC XY:

AN XY:

74368

show subpopulations

African (AFR)

AF:

0.0000241

AC:

AN:

41466

American (AMR)

AF:

0.00

AC:

AN:

15286

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3472

East Asian (EAS)

AF:

0.00

AC:

AN:

5188

South Asian (SAS)

AF:

0.00

AC:

AN:

4834

European-Finnish (FIN)

AF:

0.00

AC:

AN:

10622

Middle Eastern (MID)

AF:

0.00

AC:

AN:

316

European-Non Finnish (NFE)

AF:

0.00

AC:

AN:

68034

Other (OTH)

AF:

0.00

AC:

AN:

2094

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.625

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.0000636

Hom.:

Bravo

AF:

0.00000756

ExAC

AF:

0.0000248

AC:

ClinVar

Significance: Pathogenic/Likely pathogenic

Submissions summary: Pathogenic:3

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

Desbuquois dysplasia 1

Pathogenic:1

Nov 01, 2009

OMIM

Significance:Pathogenic

Review Status:no assertion criteria provided

Collection Method:literature only

- -

Inborn genetic diseases

Pathogenic:1

Jul 14, 2017

Ambry Genetics

Significance:Pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

not provided

Pathogenic:1

Jun 17, 2024

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Likely pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 300 of the CANT1 protein (p.Arg300Cys). This variant is present in population databases (rs267606701, gnomAD 0.006%). This missense change has been observed in individuals with Desbuquois dysplasia (PMID: 19853239). ClinVar contains an entry for this variant (Variation ID: 279). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CANT1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects CANT1 function (PMID: 19853239, 21037275). This variant disrupts the p.Arg300 amino acid residue in CANT1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19853239, 22539336). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Pathogenic

0.92

BayesDel_addAF

Pathogenic

0.39

BayesDel_noAF

Pathogenic

0.50

CADD

Pathogenic

(source)

DANN

Pathogenic

1.0

DEOGEN2

Pathogenic

0.94

D;D;D;D

Eigen

Pathogenic

0.75

Eigen_PC

Uncertain

0.63

FATHMM_MKL

Uncertain

0.94

LIST_S2

Pathogenic

0.98

D;.;.;.

M_CAP

Pathogenic

0.69

MetaRNN

Pathogenic

0.99

D;D;D;D

MetaSVM

Pathogenic

1.0

MutationAssessor

Pathogenic

3.9

H;H;H;H

PhyloP100

7.6

PrimateAI

Uncertain

0.74

PROVEAN

Pathogenic

-7.5

.;D;D;.

REVEL

Pathogenic

0.94

Sift

Pathogenic

0.0

.;D;D;.

Sift4G

Pathogenic

0.0

D;D;D;D

Polyphen

1.0

D;D;D;D

Vest4

0.84

MutPred

0.98

Gain of catalytic residue at P299 (P = 0.0118);Gain of catalytic residue at P299 (P = 0.0118);Gain of catalytic residue at P299 (P = 0.0118);Gain of catalytic residue at P299 (P = 0.0118);

MVP

1.0

MPC

1.3

ClinPred

1.0

GERP RS

4.3

RBP_binding_hub_radar

0.0

RBP_regulation_power_radar

1.1

Varity_R

0.94

gMVP

0.92

Mutation Taster

=1/99

disease causing (ClinVar)

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.010

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over